Product Overview

3,4-Dihydro-2H-1,5-benzodioxo-7-ylboronic acid is an important pharmaceutical intermediate widely used in the construction and synthesis of novel drug molecules, especially in the coupling reactions of oxygen-containing heterocyclic compounds. This product is suitable for different stages of drug development, from small-scale preparation to pilot-scale amplification and commercial production, serving as a key starting material or structural modification unit to help customers efficiently advance the new drug development process.

Applications

• Used for the construction and synthesis of oxygen-containing heterocyclic drug molecules
• As a key precursor in the Suzuki-Miyaura coupling reaction
• As a core intermediate in the development of antitumor, antiviral, and central nervous system drugs
• Supports the directed synthesis of peptides and complex organic molecules
• Suitable for customized synthesis and process optimization of pharmaceutical intermediates

Quality & Supply Capability

English Name: 3,4-Dihydro-2H-1,5-benzodioxepin-7-ylboronic acid Properties: White to off-white solid with a stable benzodioxanone heterocyclic structure and boric acid functional groups. It exhibits good reactivity and chemical stability, making it suitable for various organic synthesis reactions. Storage Recommendations: Store in a sealed, light-protected, and dry place, subject to the specific COA/MSDS. Supply Capabilities: Samples, gram-level, kilogram-level, commercial batches. Packaging Specifications: Aluminum foil bags, fluorinated bottles, cardboard drums, customized packaging. Documentation Support: COA, MSDS, HPLC, NMR, etc. We provide a full-process service from laboratory sample supply to small-scale preparation, pilot-scale amplification, and customized batch production. We can flexibly adjust purity standards, impurity control requirements, packaging specifications, and delivery cycles according to customer needs, while providing complete quality documentation support. We also provide technical support from the early stages of R&D to industrial scale-up, assisting customers in completing process development, route optimization, and project transformation, ensuring that products stably, reliably, and compliantly meet the needs of various application scenarios.

Why Choose Bioncan

Focused on pharmaceutical intermediates, possessing extensive product portfolio and technological reserves. Full-scale supply capabilities, covering all stages from laboratory to commercialization. Provides complete quality control documentation to ensure product compliance with international standards and regulations. Customized synthesis and process optimization can be performed according to specific customer needs. Supports scale-up production technology to help customers achieve a seamless transition from R&D to mass production.

Online Consulting

For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 279261-89-1, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.